Hepatic arterial infusion chemotherapy combined with anti-PD-1/PD-L1 immunotherapy and molecularly targeted agents for advanced hepatocellular carcinoma: a real world study

BACKGROUND: Molecular targeted therapy combined with immunotherapy significantly improves the prognosis of patients with advanced liver cancer. Additionally, hepatic arterial infusion chemotherapy (HAIC) can improve the prognosis of patients with advanced liver cancer. This real-world study aimed to...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Weihao, Zhang, Kai, Liu, Changfu, Gao, Wei, Si, Tongguo, Zou, Qiang, Guo, Zhi, Yang, Xueling, Li, Mei, Liu, Dongming, Mu, Han, Li, Huikai, Yu, Haipeng, Xing, Wenge
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10169627/
https://www.ncbi.nlm.nih.gov/pubmed/37180098
http://dx.doi.org/10.3389/fimmu.2023.1127349

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10169627/
https://www.ncbi.nlm.nih.gov/pubmed/37180098
http://dx.doi.org/10.3389/fimmu.2023.1127349

Ejemplares similares